Search for: "Myers v. Stephens" Results 41 - 60 of 89
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jun 2017, 12:47 pm by Mark Walsh
Justice Stephen Breyer is next with the opinion in McWilliams v. [read post]
15 Apr 2013, 7:56 am by INFORRM
The defendent, Rachel Myers, withdrew her allegations unreservedly and apologised to Lady Colthurst “for the distress and embarrassment which this matter caused [the Claimant]. [read post]
5 Jun 2017, 4:18 am by Edith Roberts
” At PrawfsBlawg, Stephen Sachs maintains that the court’s opinion in personal-jurisdiction case BNSF Railway Co. v. [read post]
2 Jul 2007, 1:04 am
More than most novice justices, Alito has taken bullets for business in the term just ended, most notably for his controversial majority opinion in Ledbetter v. [read post]
29 Jun 2016, 6:13 am by Barry Sookman
The decision by Justice Tremblay-Lamer in Bell Canada v ITVBOX.NET 2016 FC 612 to grant the injunction was not surprising. [read post]
31 Dec 2022, 3:12 pm by James Romoser
Dellinger was a longtime faculty member at Duke Law School, and he founded the appellate practice at O’Melveny & Myers. [read post]
29 Jan 2009, 5:04 am
 A former clerk for  Justice Stephen Breyer, Danielle took a leave of absence from Skadden to be Deputy National Policy Director for the Obama campaign. [read post]
11 May 2007, 12:52 am
Splenda case, or, as it's officially known, Merisant Co. v. [read post]
7 Oct 2022, 4:09 am by Bill Marler
Officials in New Zealand investigating Hepatitis A cases linked to berries have identified a connection with a past outbreak in Europe. [read post]
17 Feb 2017, 1:34 pm by Bill Marler
Beginning in September 2016, several states, CDC, and the FDA investigated a multistate outbreak of foodborne hepatitis A. [read post]
16 May 2008, 8:03 am
: (GenericsWeb), Europe: New EBA referral T 1319/04 regarding patentability of known medicament for new treatment of same illness: (IPKat), Europe: Patentability of biotechnology in Europe: (IAM), Europe: New EPO Enlarged Board case referrals: T1319/04 Dosage Regimen, T1242/06 Essential Biological Process: (Hal Wegner), Thailand: Compulsory licensing: Affordable health for Thailand thanks to Matrix Labs: (Spicy IP), Thailand: European Parliament set to reprimand Mandelson for… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]